MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos

May 15, 2020

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

May 14, 2020

MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

May 14, 2020

MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

May 7, 2020

MediPharm Labs Australia Signs its Second GMP White-Label Deal to Supply New Zealand’s Medical Cannabis Market

May 4, 2020

MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

Apr 24, 2020

MediPharm Labs to Present at KCSA Virtual Investor Conference

Apr 16, 2020

MediPharm Labs Australia and Burleigh Heads Sign Deal to Supply White-Label GMP Certified Products to Australian Medical Patients

Apr 1, 2020

MediPharm Labs Reports Fourth Quarter and Full Year 2019 Results

Mar 30, 2020

MediPharm Labs Launches New Line of High-Quality Branded Products Across Canada

Mar 26, 2020